Plasma adrenomedullin as an indicator of prognosis after acute myocardial infarction
N Nagaya(National Cerebral and Cardiovascular Center), Hiroshi Nonogi(Kyoto Medical Center), Yuji Yoshitomi(National Cerebral and Cardiovascular Center), Yoichi Goto(United Cerebral Palsy), Kenji Kangawa(National Cerebral and Cardiovascular Center), H. Matsuo(Kyoto University), Sunao Kojima(Kumamoto University), S Miyazaki(National Cerebral and Cardiovascular Center), M Kuramochi(National Cerebral and Cardiovascular Center), Masaaki Uematsu(National Cerebral and Cardiovascular Center), Yuji Miyao(National Cerebral and Cardiovascular Center), Toshio Nishikimi(Kyoto University)
Cited by 63
Related Papers
Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary Hypertension
|Circulation|2000|880
Plasma Brain Natriuretic Peptide Levels Increase in Proportion to the Extent of Right Ventricular Dysfunction in Pulmonary Hypertension
|Journal of the American College of Cardiology|1998|578
The role of natriuretic peptides in cardioprotection
|Cardiovascular Research|2005|483
Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure.
|Journal of Clinical Investigation|1994|478